zoledronic acid has been researched along with Paraproteinemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Englund, K; Hatch, C; Hussein, MA; Isada, C; Karam, MA; Licata, A; Reed, J; Richmond, M; Smith, J; Thakkar, SG; Tomford, JW | 1 |
| Crawford, B; Gibson, J; Iland, H; Joshua, D; Joy Ho, P; Sanders, J | 1 |
1 trial(s) available for zoledronic acid and Paraproteinemias
| Article | Year |
|---|---|
Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS).
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Middle Aged; Multiple Myeloma; Osteoporosis; Paraproteinemias; Zoledronic Acid | 2007 |
1 other study(ies) available for zoledronic acid and Paraproteinemias
| Article | Year |
|---|---|
Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.
Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Male; Middle Aged; Osteomyelitis; Osteonecrosis; Pamidronate; Paraproteinemias; Zoledronic Acid | 2006 |